IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $408 | -99.9% | 10,811 | -1.7% | 1.03% | -21.3% |
| Q3 2022 | $486,000 | +17.1% | 10,993 | -2.0% | 1.31% | +39.2% |
| Q2 2022 | $415,000 | -16.7% | 11,222 | +35.0% | 0.94% | +84.7% |
| Q3 2019 | $498,000 | -6.7% | 8,314 | 0.0% | 0.51% | -6.2% |
| Q2 2019 | $534,000 | -23.7% | 8,314 | -3.7% | 0.54% | -25.2% |
| Q1 2019 | $700,000 | +59.1% | 8,629 | +6.0% | 0.73% | +22.9% |
| Q4 2018 | $440,000 | +1417.2% | 8,140 | +1118.6% | 0.59% | +2017.9% |
| Q1 2018 | $29,000 | -86.1% | 668 | -83.9% | 0.03% | -86.7% |
| Q4 2017 | $209,000 | +40.3% | 4,154 | +41.1% | 0.21% | +24.3% |
| Q3 2017 | $149,000 | -15.8% | 2,944 | -15.4% | 0.17% | +87.8% |
| Q2 2017 | $177,000 | +28.3% | 3,481 | +1.2% | 0.09% | +18.4% |
| Q1 2017 | $138,000 | -86.2% | 3,440 | -78.7% | 0.08% | -78.1% |
| Q4 2015 | $1,001,000 | – | 16,161 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |